Cancers arise owing to the accumulation of mutations in critical genes that alter normal
programmes of cell proliferation, differentiation and death. As the first stage of a systematic …

Cancers arise owing to mutations in a subset of genes that confer growth advantage. The
availability of the human genome sequence led us to propose that systematic resequencing of …

Breast cancer risk is influenced by rare coding variants in susceptibility genes, such as
BRCA1, and many common, mostly non-coding variants. However, much of the genetic …

Breast cancer is the most common cancer among women. Common variants at 27 loci have
been identified as associated with susceptibility to breast cancer, and these account for ∼9…

The protein-kinase family is the most frequently mutated gene family found in human cancer
and faulty kinase enzymes are being investigated as promising targets for the design of …

Prostate cancer is the most frequently diagnosed cancer in males in developed countries.
To identify common prostate cancer susceptibility alleles, we genotyped 211,155 SNPs on a …

Large-scale systematic resequencing has been proposed as the key future strategy for the
discovery of rare, disease-causing sequence variants across the spectrum of human complex …

During the clonal expansion of cancer from an ancestral cell with an initiating oncogenic
mutation to symptomatic neoplasm, the occurrence of somatic mutations (both driver and …

Protein kinases are frequently mutated in human cancer and inhibitors of mutant protein
kinases have proven to be effective anticancer drugs. We screened the coding sequences of …

Malignant gliomas have a very poor prognosis. The current standard of care for these
cancers consists of extended adjuvant treatment with the alkylating agent temozolomide after …